BioStem Technologies (BSEM) News Today $14.44 -0.98 (-6.36%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Headlines Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period BioStem Technologies, Inc. (OTCMKTS:BSEM) Short Interest UpdateBioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) was the target of a significant drop in short interest in November. As of November 30th, there was short interest totalling 117,700 shares, a drop of 21.2% from the November 15th total of 149,400 shares. Based on an average trading volume of 197,300 shares, the short-interest ratio is presently 0.6 days.December 13, 2024 | marketbeat.comKane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound GelNovember 27, 2024 | globenewswire.comBioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental AllograftsNovember 25, 2024 | globenewswire.comBioStem Technologies, Inc.: BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare GlobalNovember 21, 2024 | finanznachrichten.deBioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare GlobalNovember 20, 2024 | globenewswire.comQ4 EPS Estimates for OTCMKTS:BSEM Raised by Zacks Small CapBioStem Technologies, Inc. (OTCMKTS:BSEM - Free Report) - Investment analysts at Zacks Small Cap upped their Q4 2024 EPS estimates for BioStem Technologies in a research note issued to investors on Friday, November 15th. Zacks Small Cap analyst B. Sorensen now expects that the company will post eNovember 18, 2024 | marketbeat.comBSEM: Medicare Issues Shouldn’t Impact BioStemNovember 15, 2024 | finance.yahoo.comLong-Term, BioStem Technologies Still A Promising Growth StockNovember 15, 2024 | seekingalpha.comBioStem Technologies, Inc. (OTCMKTS:BSEM) Sees Significant Increase in Short InterestBioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) was the target of a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 115,100 shares, an increase of 22.3% from the October 15th total of 94,100 shares. Based on an average daily volume of 124,800 shares, the short-interest ratio is presently 0.9 days.November 15, 2024 | marketbeat.comBioStem Technologies, Inc. (BSEM) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | seekingalpha.comBSEM Continues to Exceed ExpectationsNovember 13, 2024 | msn.comBioStem Technologies Achieves Record Revenue Growth in Q3 2024November 13, 2024 | markets.businessinsider.comBioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) RegionsOctober 29, 2024 | globenewswire.comBioStem Technologies to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024October 28, 2024 | globenewswire.comOTCMKTS:BSEM Q3 EPS Estimate Raised by Zacks Small CapBioStem Technologies, Inc. (OTCMKTS:BSEM - Free Report) - Analysts at Zacks Small Cap boosted their Q3 2024 earnings per share estimates for shares of BioStem Technologies in a research note issued on Thursday, October 17th. Zacks Small Cap analyst B. Sorensen now anticipates that the company wilOctober 18, 2024 | marketbeat.comBSEM Announces Expanding Market and Stellar Test ResultsOctober 17, 2024 | msn.comBioStem Technologies, Inc. (OTCMKTS:BSEM) Short Interest Up 41.1% in SeptemberBioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) was the recipient of a large increase in short interest during the month of September. As of September 30th, there was short interest totalling 88,600 shares, an increase of 41.1% from the September 15th total of 62,800 shares. Based on an average daily trading volume, of 57,200 shares, the days-to-cover ratio is currently 1.5 days.October 13, 2024 | marketbeat.comBSEM Initiates Trial and Start Uplisting ProcessOctober 2, 2024 | msn.comBioStem Technologies Initiates BR-AC-DFU-101 Clinical Trial to Study BioREtain® in Diabetic Foot UlcersOctober 2, 2024 | globenewswire.comBioStem Technologies Inc.September 11, 2024 | wsj.comBioStem Technologies, Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ETAugust 29, 2024 | globenewswire.comBioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje® Compared to the Standard of Care for Non-Healing Diabetic Foot UlcersAugust 21, 2024 | globenewswire.comBSEM Revenues are Growing ExponentiallyAugust 13, 2024 | msn.comBioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 MillionAugust 12, 2024 | globenewswire.comBioStem Technologies is about to announce earnings — here's what Wall Street expectsAugust 11, 2024 | markets.businessinsider.comBiostem Technologies Inc (BSEM)July 24, 2024 | investing.comBioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot UlcersJuly 10, 2024 | globenewswire.comBioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care StudyJune 26, 2024 | globenewswire.comUPDATE -- PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic ExpansionJune 17, 2024 | globenewswire.comPRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic ExpansionJune 17, 2024 | globenewswire.comShort Interest in BioStem Technologies, Inc. (OTCMKTS:BSEM) Rises By 38.9%BioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) saw a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 40,700 shares, an increase of 38.9% from the May 15th total of 29,300 shares. Based on an average daily volume of 35,300 shares, the short-interest ratio is presently 1.2 days.June 15, 2024 | marketbeat.comBioStem Technologies, Inc. (OTCMKTS:BSEM) Sees Large Increase in Short InterestBioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) was the recipient of a large growth in short interest in May. As of May 15th, there was short interest totalling 29,300 shares, a growth of 31.4% from the April 30th total of 22,300 shares. Based on an average daily volume of 66,400 shares, the short-interest ratio is currently 0.4 days.May 31, 2024 | marketbeat.comBioStem Technologies to Sponsor MRO Better Half DashMay 29, 2024 | globenewswire.comBSEM Again Bests Estimates as Growth AcceleratesMay 15, 2024 | finance.yahoo.comBioStem Technologies Inc (BSEM) Q1 2024 Earnings Call Transcript Highlights: A Remarkable ...May 15, 2024 | finance.yahoo.comBioStem Technologies Reports Record First Quarter Revenue of $41.9 MillionMay 14, 2024 | globenewswire.comBioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain AllograftsApril 30, 2024 | globenewswire.comBioStem Technologies, Inc. (OTCMKTS:BSEM) Short Interest Up 152.7% in AprilBioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 37,400 shares, a growth of 152.7% from the March 31st total of 14,800 shares. Based on an average daily volume of 68,700 shares, the days-to-cover ratio is presently 0.5 days.April 26, 2024 | marketbeat.comBioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior ExchangeApril 24, 2024 | globenewswire.comBioStem Technologies, Inc. to Post Q1 2024 Earnings of $0.74 Per Share, Zacks Small Cap Forecasts (OTCMKTS:BSEM)BioStem Technologies, Inc. (OTCMKTS:BSEM - Free Report) - Investment analysts at Zacks Small Cap increased their Q1 2024 earnings per share (EPS) estimates for shares of BioStem Technologies in a report issued on Tuesday, April 2nd. Zacks Small Cap analyst B. Sorensen now expects that the companyApril 4, 2024 | marketbeat.comQ4 2023 Biostem Technologies Inc Earnings CallApril 2, 2024 | finance.yahoo.comBSEM Continues to Post Stellar ResultsApril 2, 2024 | finance.yahoo.comBioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY IncreaseApril 1, 2024 | globenewswire.comBioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024March 21, 2024 | globenewswire.comBSEM BioStem Technologies, Inc.March 9, 2024 | seekingalpha.comBioStem Technologies, Inc. (BSEM)March 9, 2024 | finance.yahoo.comBioStem Technologies Inc BSEMMarch 1, 2024 | morningstar.comBSEM: BioStem Expands and ImprovesFebruary 6, 2024 | finance.yahoo.comBSEM Provides Good Value for Great ScienceFebruary 6, 2024 | finance.yahoo.comBSEM Worth a Look on Surging RevenuesFebruary 6, 2024 | finance.yahoo.com Get BioStem Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSEM and its competitors with MarketBeat's FREE daily newsletter. Email Address $2 Trillion Disappears Because of Fed's Secretive New Move (Ad)$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth. Click here to see his new research now. BSEM Media Mentions By Week BSEM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BSEM News Sentiment▼0.000.60▲Average Medical News Sentiment BSEM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BSEM Articles This Week▼01▲BSEM Articles Average Week Get BioStem Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSEM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Rocket Pharmaceuticals News Today OPKO Health News Today Bicycle Therapeutics News Today Avadel Pharmaceuticals News Today Owens & Minor News Today Vir Biotechnology News Today Brookdale Senior Living News Today CeriBell News Today Curaleaf News Today The Pennant Group News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BSEM) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioStem Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioStem Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BSEM Stock Alerts